Table: Aska Pharmaceutical - 6-MTH group results

ASKA Pharmaceutical Holdings

05/11/2018 06:00

Nov 5 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             23.48               25.05            49.00    
                 (-6.3 pct)          (+3.0 pct)       (+0.1 pct)  
  Operating        960 mln               1.87             1.00    
                 (-48.7 pct)         (+40.5 pct)      (-64.6 pct) 
  Recurring          1.08                1.99             1.20    
                 (-45.9 pct)         (+36.9 pct)      (-61.0 pct) 
  Net              743 mln               1.64             1.00    
                 (-54.7 pct)         (+28.8 pct)      (-58.1 pct) 
  EPS             26.36 yen           58.35 yen        35.47 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div         7.00 yen            7.00 yen                    
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T